Advancing global herbal medicine: Enhancing herb quality through innovative strategies explored in Hong Kong - An international hub
The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negat...
Saved in:
Published in | Phytomedicine Plus : International journal of phytotherapy and phytopharmacology Vol. 5; no. 1; p. 100727 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.02.2025
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted.
This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong.
We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong.
Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns.
The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale. |
---|---|
AbstractList | Background: The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted. Purpose: This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong. Study Design: We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong. Results: Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns. Conclusion: The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale. The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted. This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong. We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong. Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns. The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale. |
ArticleNumber | 100727 |
Author | Shaw, Pang-Chui Ngai, Hiu-Lam |
Author_xml | – sequence: 1 givenname: Hiu-Lam surname: Ngai fullname: Ngai, Hiu-Lam organization: School of Life Sciences, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, PR China – sequence: 2 givenname: Pang-Chui surname: Shaw fullname: Shaw, Pang-Chui email: pcshaw@cuhk.edu.hk organization: School of Life Sciences, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, PR China |
BookMark | eNqFUU1r3DAQFSGFpGn-QQ_6A97KkmzZpRSWkDahgVzSs9DHyNZWkbayd-me-8crZ0MJueSiGd7MezOj9x6dxhQBoY81WdWkbj9tVtvxsA27FSWUF4gIKk7QOW1bURFWs9MX-Rm6nKYNIYQ2Nat7fo7-ru1eRePjgIeQtAp4hLyER7C-wPAZX8fxuWMp4d87Ffx8wPOY024YsY8x7dXs94CnOasZBg8Thj_bkDLYUsY3qXB_LE-F17EgM-RYGCku43b6A3rnVJjg8jleoJ_frh-ubqq7---3V-u7yjDWiKo1DXcN4x0B27Sd7gTXlLcGuLZcQyM416YBWtKeM9cLRkoL6VRvNDPOsgt0e9S1SW3kNvtHlQ8yKS-fgJQHqfLsTQDZOd7buu2d1g0XnesoUVYwB5aCLQsULX7UMjlNUwb3X68mcvFFlglPvsjFF3n0pdC-HmlQ7tx7yHIyHqIpn53BzGUR_5bAl1cCJvjojQq_4PA2_R-ZN7Cd |
Cites_doi | 10.1371/journal.pone.0267143 10.1201/9781003580782-3 10.3389/fphar.2019.01227 10.1186/s13012-017-0605-9 10.1248/yakushi.20-00196-1 10.1186/s13020-018-0188-7 10.12688/wellcomeopenres.15236.1 10.1016/j.jsps.2023.02.013 10.1016/j.jtcme.2021.07.005 10.1038/s41598-017-07538-5 |
ContentType | Journal Article |
Copyright | 2024 The Author(s) |
Copyright_xml | – notice: 2024 The Author(s) |
DBID | 6I. AAFTH AAYXX CITATION DOA |
DOI | 10.1016/j.phyplu.2024.100727 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2667-0313 |
ExternalDocumentID | oai_doaj_org_article_8f49d169fbb5478f820ad73fed2ed80e 10_1016_j_phyplu_2024_100727 S266703132400201X |
GroupedDBID | .1- .FO 0R~ AAEDW AAHBH AALRI AAXUO AAYWO ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS FDB GROUPED_DOAJ M~E OK1 ROL Z5R 6I. AAFTH AAYXX CITATION |
ID | FETCH-LOGICAL-c3357-6c54f53480ed568b874b246ce4bd4be5744bc5e2be5943f973087408a9cb3cfd3 |
IEDL.DBID | DOA |
ISSN | 2667-0313 |
IngestDate | Wed Aug 27 01:31:55 EDT 2025 Tue Jul 01 01:53:42 EDT 2025 Sat Feb 15 15:52:11 EST 2025 Tue Aug 26 17:26:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HACCP Herb market HKCSCMM DH Herb quality problem GMP JADER HKCMMS Supply chain Chinese medicine pharmacist registration SOP GAP HKPC CMRO Centralized purchase system WHO |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3357-6c54f53480ed568b874b246ce4bd4be5744bc5e2be5943f973087408a9cb3cfd3 |
OpenAccessLink | https://doaj.org/article/8f49d169fbb5478f820ad73fed2ed80e |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8f49d169fbb5478f820ad73fed2ed80e crossref_primary_10_1016_j_phyplu_2024_100727 elsevier_sciencedirect_doi_10_1016_j_phyplu_2024_100727 elsevier_clinicalkey_doi_10_1016_j_phyplu_2024_100727 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2025 2025-02-00 2025-02-01 |
PublicationDateYYYYMMDD | 2025-02-01 |
PublicationDate_xml | – month: 02 year: 2025 text: February 2025 |
PublicationDecade | 2020 |
PublicationTitle | Phytomedicine Plus : International journal of phytotherapy and phytopharmacology |
PublicationYear | 2025 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Au, C.T., Chow, Y.L., 2022. The feasibility of implementation of the accreditation and registration for the professionals of Chinese medicine pharmacists in Hong Kong (Research Report). Lo, Yik, Shaw (bib0013) 2018; 13 Wong, Lam, Bian (bib0020) 2017; 7 Ngai, Yang, Chu (bib0014) 2022; 17 Hong Kong Productivity Council, 2014. Guidelines for quality management procedures in traditional Chinese medicine business operations. Atkins, Francis, Islam (bib0001) 2017; 12 Office Of The Ombudsman of Hong Kong, 2018. Government's proactive investigation report on the regulation of unregistered Chinese patent medicine products. Yu, Song, Lei (bib0023) 2023; 31 Yik, Wong, Wong (bib0022) 2021; 11 Chinese Medicine Regulatory Office, Department of Health, 2024a. Import and export control of Chinese medicines. Zhang, Cao, Zhang (bib0024) 2021 Chinese Medicine Regulatory Office, Department of Health, 2024b. Chinese medicines recall. Pisani, Nistor, Hasnida (bib0016) 2019; 4 Bastille Post. 16 January 2019. The Department of Health was suspected of ineffective control, and the first inspection of Chinese herbal medicines exceeded the standard, and no announcement on the reduced toxicity after the decoction was prepared. Ichim (bib0011) 2019; 10 Chinese Medicine Regulatory Office, Department of Health, 2021. Revised Hong Kong standards for maximum residue limits of harmful substances in chinese medicinal materials and related implementation plans. Accessed 17 Feb 2024. Leung, Cheng (bib0012) 2021; 8 The Audit Commission, 2009. Chapter 4 - control of chinese medicines. In report No 53 of the director of audit. Chinese Medicine Division of the Department of Health, 2024. Hong Kong Chinese materia medica standards. Department of Justice, 2024. Cap. 362 trade descriptions ordinance. Hong Kong Productivity Council, 2024. Hong Kong certification scheme for chinese materia medica and decoction pieces. Awuchi (bib0003) 2023; 9 Accessed 17 February 2024. Sakai (bib0017) 2021; 141 (bib0021) 2017 Sakai (10.1016/j.phyplu.2024.100727_bib0017) 2021; 141 Wong (10.1016/j.phyplu.2024.100727_bib0020) 2017; 7 Awuchi (10.1016/j.phyplu.2024.100727_bib0003) 2023; 9 Yu (10.1016/j.phyplu.2024.100727_bib0023) 2023; 31 Ichim (10.1016/j.phyplu.2024.100727_bib0011) 2019; 10 Yik (10.1016/j.phyplu.2024.100727_bib0022) 2021; 11 Atkins (10.1016/j.phyplu.2024.100727_bib0001) 2017; 12 Lo (10.1016/j.phyplu.2024.100727_bib0013) 2018; 13 10.1016/j.phyplu.2024.100727_bib0010 Pisani (10.1016/j.phyplu.2024.100727_bib0016) 2019; 4 (10.1016/j.phyplu.2024.100727_bib0021) 2017 10.1016/j.phyplu.2024.100727_bib0004 10.1016/j.phyplu.2024.100727_bib0015 10.1016/j.phyplu.2024.100727_bib0002 10.1016/j.phyplu.2024.100727_bib0007 10.1016/j.phyplu.2024.100727_bib0008 10.1016/j.phyplu.2024.100727_bib0019 10.1016/j.phyplu.2024.100727_bib0005 10.1016/j.phyplu.2024.100727_bib0006 10.1016/j.phyplu.2024.100727_bib25 Ngai (10.1016/j.phyplu.2024.100727_bib0014) 2022; 17 10.1016/j.phyplu.2024.100727_bib0009 Leung (10.1016/j.phyplu.2024.100727_bib0012) 2021; 8 Zhang (10.1016/j.phyplu.2024.100727_bib0024) 2021 |
References_xml | – reference: Hong Kong Productivity Council, 2014. Guidelines for quality management procedures in traditional Chinese medicine business operations. – volume: 13 start-page: 1 year: 2018 end-page: 8 ident: bib0013 article-title: Effective authentication of placenta hominis publication-title: Chin. Med. – volume: 4 start-page: 70 year: 2019 ident: bib0016 article-title: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania publication-title: Wellcome Open. Res. – volume: 141 start-page: 165 year: 2021 end-page: 168 ident: bib0017 article-title: Role and applicability of spontaneous reporting databases in medical big data (医療ビッグデータにおける自発報告データベースの位置づけと利用可能性) publication-title: Yakugaku Zasshi – volume: 12 start-page: 1 year: 2017 end-page: 18 ident: bib0001 article-title: A guide to using the theoretical domains framework of behaviour change to investigate implementation problems publication-title: Implement. Sci. – reference: Chinese Medicine Regulatory Office, Department of Health, 2021. Revised Hong Kong standards for maximum residue limits of harmful substances in chinese medicinal materials and related implementation plans. – reference: Department of Justice, 2024. Cap. 362 trade descriptions ordinance. – reference: Chinese Medicine Division of the Department of Health, 2024. Hong Kong Chinese materia medica standards. – year: 2017 ident: bib0021 article-title: WHO global surveillance and monitoring system for substandard and falsified medical products – volume: 31 start-page: 597 year: 2023 end-page: 604 ident: bib0023 article-title: Anti-fatigue effect of traditional Chinese medicines: a review publication-title: Saudi Pharm. J. – volume: 11 start-page: 598 year: 2021 end-page: 600 ident: bib0022 article-title: HerBChain, a blockchain-based informative platform for quality assurance and quality control of herbal products publication-title: J. Tradit. Complement. Med. – reference: Chinese Medicine Regulatory Office, Department of Health, 2024a. Import and export control of Chinese medicines. – reference: . Accessed 17 February 2024. – volume: 10 start-page: 1227 year: 2019 ident: bib0011 article-title: The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration publication-title: Front. Pharmacol. – volume: 8 start-page: 1 year: 2021 end-page: 6 ident: bib0012 article-title: Quality control of medicinal herbs—has good agricultural practice (GAP) helped? publication-title: Open Access Library Journal – reference: Hong Kong Productivity Council, 2024. Hong Kong certification scheme for chinese materia medica and decoction pieces. – volume: 17 year: 2022 ident: bib0014 article-title: Multi-methodological approach for the quality assessment of senecionis scandentis herba (Qianliguang) in the herbal market publication-title: PLoS. One – start-page: 1 year: 2021 end-page: 7 ident: bib0024 article-title: Construction status and development strategy of GAP bases for chinese herbal medicine publication-title: China J. Chin. Materia Medica – volume: 9 year: 2023 ident: bib0003 article-title: HACCP, quality, and food safety management in food and agricultural systems publication-title: Cogent. Food Agric. – reference: Bastille Post. 16 January 2019. The Department of Health was suspected of ineffective control, and the first inspection of Chinese herbal medicines exceeded the standard, and no announcement on the reduced toxicity after the decoction was prepared. – reference: Chinese Medicine Regulatory Office, Department of Health, 2024b. Chinese medicines recall. – reference: . Accessed 17 Feb 2024. – volume: 7 start-page: 7513 year: 2017 ident: bib0020 article-title: Morbidity pattern of traditional Chinese medicine primary care in the Hong Kong population publication-title: Sci Rep. – reference: The Audit Commission, 2009. Chapter 4 - control of chinese medicines. In report No 53 of the director of audit. – reference: Au, C.T., Chow, Y.L., 2022. The feasibility of implementation of the accreditation and registration for the professionals of Chinese medicine pharmacists in Hong Kong (Research Report). – reference: Office Of The Ombudsman of Hong Kong, 2018. Government's proactive investigation report on the regulation of unregistered Chinese patent medicine products. – ident: 10.1016/j.phyplu.2024.100727_bib0002 – volume: 9 issue: 1 year: 2023 ident: 10.1016/j.phyplu.2024.100727_bib0003 article-title: HACCP, quality, and food safety management in food and agricultural systems publication-title: Cogent. Food Agric. – ident: 10.1016/j.phyplu.2024.100727_bib0005 – volume: 17 issue: 4 year: 2022 ident: 10.1016/j.phyplu.2024.100727_bib0014 article-title: Multi-methodological approach for the quality assessment of senecionis scandentis herba (Qianliguang) in the herbal market publication-title: PLoS. One doi: 10.1371/journal.pone.0267143 – ident: 10.1016/j.phyplu.2024.100727_bib0006 – ident: 10.1016/j.phyplu.2024.100727_bib0004 doi: 10.1201/9781003580782-3 – volume: 8 start-page: 1 issue: 12 year: 2021 ident: 10.1016/j.phyplu.2024.100727_bib0012 article-title: Quality control of medicinal herbs—has good agricultural practice (GAP) helped? publication-title: Open Access Library Journal – volume: 10 start-page: 1227 year: 2019 ident: 10.1016/j.phyplu.2024.100727_bib0011 article-title: The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.01227 – volume: 12 start-page: 1 issue: 1 year: 2017 ident: 10.1016/j.phyplu.2024.100727_bib0001 article-title: A guide to using the theoretical domains framework of behaviour change to investigate implementation problems publication-title: Implement. Sci. doi: 10.1186/s13012-017-0605-9 – volume: 141 start-page: 165 issue: 2 year: 2021 ident: 10.1016/j.phyplu.2024.100727_bib0017 article-title: Role and applicability of spontaneous reporting databases in medical big data (医療ビッグデータにおける自発報告データベースの位置づけと利用可能性) publication-title: Yakugaku Zasshi doi: 10.1248/yakushi.20-00196-1 – ident: 10.1016/j.phyplu.2024.100727_bib0009 – ident: 10.1016/j.phyplu.2024.100727_bib0010 – volume: 13 start-page: 1 issue: 1 year: 2018 ident: 10.1016/j.phyplu.2024.100727_bib0013 article-title: Effective authentication of placenta hominis publication-title: Chin. Med. doi: 10.1186/s13020-018-0188-7 – year: 2017 ident: 10.1016/j.phyplu.2024.100727_bib0021 – ident: 10.1016/j.phyplu.2024.100727_bib0008 – start-page: 1 year: 2021 ident: 10.1016/j.phyplu.2024.100727_bib0024 article-title: Construction status and development strategy of GAP bases for chinese herbal medicine publication-title: China J. Chin. Materia Medica – ident: 10.1016/j.phyplu.2024.100727_bib25 – ident: 10.1016/j.phyplu.2024.100727_bib0007 – ident: 10.1016/j.phyplu.2024.100727_bib0015 – volume: 4 start-page: 70 year: 2019 ident: 10.1016/j.phyplu.2024.100727_bib0016 article-title: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania publication-title: Wellcome Open. Res. doi: 10.12688/wellcomeopenres.15236.1 – volume: 31 start-page: 597 issue: 4 year: 2023 ident: 10.1016/j.phyplu.2024.100727_bib0023 article-title: Anti-fatigue effect of traditional Chinese medicines: a review publication-title: Saudi Pharm. J. doi: 10.1016/j.jsps.2023.02.013 – ident: 10.1016/j.phyplu.2024.100727_bib0019 – volume: 11 start-page: 598 issue: 6 year: 2021 ident: 10.1016/j.phyplu.2024.100727_bib0022 article-title: HerBChain, a blockchain-based informative platform for quality assurance and quality control of herbal products publication-title: J. Tradit. Complement. Med. doi: 10.1016/j.jtcme.2021.07.005 – volume: 7 start-page: 7513 year: 2017 ident: 10.1016/j.phyplu.2024.100727_bib0020 article-title: Morbidity pattern of traditional Chinese medicine primary care in the Hong Kong population publication-title: Sci Rep. doi: 10.1038/s41598-017-07538-5 |
SSID | ssj0002513194 |
Score | 2.2819507 |
Snippet | The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to... Background: The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified... |
SourceID | doaj crossref elsevier |
SourceType | Open Website Index Database Publisher |
StartPage | 100727 |
SubjectTerms | Centralized purchase system Chinese medicine pharmacist registration Herb market Herb quality problem Supply chain |
Title | Advancing global herbal medicine: Enhancing herb quality through innovative strategies explored in Hong Kong - An international hub |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S266703132400201X https://dx.doi.org/10.1016/j.phyplu.2024.100727 https://doaj.org/article/8f49d169fbb5478f820ad73fed2ed80e |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BTtwwELUqTlwqWopYSqs5IE4bkcR24vRG0aIV1SIOrLS3KLbHYhEKCHaR9tJLf7xjO4Hc9sIliWI7sTwjz0wy8x5jJ3lqeNrkmGijKEBRqUyqkpMuV9ph5jLEgM4_uy6mc3G1kIsB1ZfPCYvwwHHhzpQTlc2KymntoaccWazGltyhzdGqFP3uSzZvEEz5PZisNumW6GvlQkIXTfvpYU0hYS5CboAnkhnYogDZPzBJAzNzucc-d_4hnMd5fWGfsP3KTm8iwPRmDLfv9VIvYziFm3fo6c0--xdIkg2ZI4hIH0Dd_an_hf4LJu1d18M3QSyq3EDH1wPLjiX1FeFl1cNIAIZMPbTUDNNHGvvHHxI4b2E5_KQId2v9jc0vJ7cX06SjWUgM57JMCiOFk5zkhFYWSqtS6FwUBoW2QqMshdBGYk6XleCORJl6Hj_VVEZz4yw_YDvtY4uHDExhjdIUrPMiFZiZBi1vCuV0k3GplByxpF_w-imiadR9mtl9HQVUewHVUUAj9ttL5a2vx8ION0hD6k5D6m0aMmKyl2ndl5vSBkkPWm55efk2rnNHopuxdeTRR0z7O9vNPddwyBA_Zjur5zX-IAdopX8GXafj7O_kP-dXCSo |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancing+global+herbal+medicine%3A+Enhancing+herb+quality+through+innovative+strategies+explored+in+Hong+Kong+-+An+international+hub&rft.jtitle=Phytomedicine+Plus+%3A+International+journal+of+phytotherapy+and+phytopharmacology&rft.au=Ngai%2C+Hiu-Lam&rft.au=Shaw%2C+Pang-Chui&rft.date=2025-02-01&rft.pub=Elsevier+B.V&rft.issn=2667-0313&rft.eissn=2667-0313&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1016%2Fj.phyplu.2024.100727&rft.externalDocID=S266703132400201X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2667-0313&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2667-0313&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2667-0313&client=summon |